Viokace
Pancrelipase · Aimmune Therapeutics, Inc.
PRESCRIPTION ONLY (USA)Viokace ingredients
| Active ingredient | Strength |
|---|---|
| Pancrelipase Lipase | 20880 [USP'U]/1, 10440 [USP'U]/1 |
| Pancrelipase Protease | 78300 [USP'U]/1, 39150 [USP'U]/1 |
| Pancrelipase Amylase | 78300 [USP'U]/1, 39150 [USP'U]/1 |
What Viokace is used for
Viokace is a specialist medicine. Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Viokace
- Generic name
- Pancrelipase
- Made by
- Aimmune Therapeutics, Inc.
- Forms
- Tablet
- Given
- Oral
- FDA approval
- Biologic licence (BLA) BLA022542
- On the US market since
- 2021
Official information
- Viokace prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Pancrelipase)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Viokace?
Viokace (Pancrelipase) is a specialist medicine made by Aimmune Therapeutics, Inc., approved by the US FDA.
What are the ingredients of Viokace?
Viokace contains Pancrelipase Lipase (20880 [USP'U]/1, 10440 [USP'U]/1); Pancrelipase Protease (78300 [USP'U]/1, 39150 [USP'U]/1); Pancrelipase Amylase (78300 [USP'U]/1, 39150 [USP'U]/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA